ClearValue Team Insights
Stay ahead of the curve by accessing the most recent insights from our expert team. Dive into comprehensive analyses and timely updates covering a spectrum of investment-related news and events.
$NVAX Receives FDA Approval, Key Price Targets After 10%+ Intraday Rally
Novavax (NVAX) has been one of our best performing stocks that has been trading in an accumulation range between $7 and $9. I believe that NVAX is trending for an upward breakout in Q4. The FDA has approved NVAX’s COVID vaccine for patient ages 12+, and the European Union is set to make a decision […]Read More
$BTC Reached my October Price Target in 2 Days, Retests a Key Support Level
I published a Q3 chart analysis and Q4 forecast for Bitcoin with $28.5k as a key price level to monitor. BTC showed a lot of bullishness over the first few days in October, and has reached the price target in just two days. BTC has been in a correction, and has found support in this […]Read More
S&P 500: $SPX Lost Support Today, Next Key Price Targets to Monitor
SPX lost a key support level at the orange support zone today. I think the white trend line and yellow support zones will be key support levels if the S&P forms another dead cat bounce or is bearish tomorrow. TradingView Chart: https://www.tradingview.com/chart/SPX/tEPuXlEs-SPX-Lost-Support-Today-Next-Key-Price-Targets-to-Monitor/
Read More